Market Insight - TESCM: is pharma keeping pace with modern practices?
This article was originally published in Scrip
Executive Summary
Multinational pharma companies generally operate to a vertically integrated business model, which by its very nature transcends national boundaries. Yet despite the international reach of such large companies, the fundamental activity of R&D is often performed in just one country (the company's country of origin). Moreover, the manufacturing of finished products normally takes place in just one or a few countries.